Eli Lilly Announces 3.5 Billion Dollar Investment in New Pennsylvania Manufacturing Facility
Eli Lilly announced plans to build a pharmaceutical facility in Pennsylvania to produce weight-loss drugs. The project will create at least 850 local jobs.
Insights:
Eli Lilly and Company announced it will build a $3.5 billion pharmaceutical manufacturing facility in the Lehigh Valley region of Pennsylvania. This new site will focus on the production of the company’s injectable weight-loss medications, including retatrutide. The project represents the largest investment by a life sciences company in the history of Pennsylvania.
